DSP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.47409989664982E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.94139999631915E-08 |
Normal-vs-Stage2 |
1.00369999977978E-07 |
Normal-vs-Stage3 |
7.782600E-04 |
Normal-vs-Stage4 |
1.3272050125579E-11 |
Stage1-vs-Stage2 |
2.363400E-01 |
Stage1-vs-Stage3 |
7.010800E-01 |
Stage1-vs-Stage4 |
1.50133999999857E-05 |
Stage2-vs-Stage3 |
4.832200E-01 |
Stage2-vs-Stage4 |
1.813940E-02 |
Stage3-vs-Stage4 |
3.497200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.94130045372276E-10 |
Normal-vs-AfricanAmerican |
4.41460000000227E-05 |
Normal-vs-Asian |
5.37399999944732E-07 |
Caucasian-vs-AfricanAmerican |
2.137200E-01 |
Caucasian-vs-Asian |
2.251000E-01 |
AfricanAmerican-vs-Asian |
1.079360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.79449788362263E-11 |
Normal-vs-Female |
7.004500E-04 |
Male-vs-Female |
1.392200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.2243999999727E-06 |
Normal-vs-Extreme_Weight |
1.53089985133192E-10 |
Normal-vs-Obese |
6.14119999999829E-05 |
Normal-vs-Extreme_Obese |
1.491550E-02 |
Normal_Weight-vs-Extreme_Weight |
6.469400E-01 |
Normal_Weight-vs-Obese |
2.508400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.380000E-01 |
Extreme_Weight-vs-Obese |
5.434400E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.129200E-01 |
Obese-vs-Extreme_Obese |
6.306400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.761900E-02 |
Normal-vs-Age(41-60Yrs) |
6.37620000021322E-07 |
Normal-vs-Age(61-80Yrs) |
4.20899981534717E-11 |
Normal-vs-Age(81-100Yrs) |
7.56239959542881E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.959000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.647000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.716200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.834300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.147980E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.103500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.80129999699719E-08 |
Normal-VS-Type2 PRCC |
2.05002681497035E-12 |
Normal-VS-KIRP CIMP |
3.441600E-01 |
Normal-VS-Unclassified PRCC |
4.05159999999904E-05 |
Type1 PRCC-VS-Type2 PRCC |
6.611800E-04 |
Type1 PRCC-VS-KIRP CIMP |
6.054000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.596800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.692000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.132000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.842600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.69469993593907E-11 |
Normal-vs-N1 |
6.495400E-03 |
Normal-vs-N2 |
4.49359999999954E-05 |
N0-vs-N1 |
1.381640E-01 |
N0-vs-N2 |
6.969600E-01 |
N1-vs-N2 |
3.754200E-01 |
|
|